Compare Godaddy Inc (GDDY) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Godaddy Inc vs IDEXX Laboratories, Inc. — how do they compare? Godaddy Inc trades at $92.81 (market cap $12.09B), while IDEXX Laboratories, Inc. trades at $577.11 (market cap $43.94B). The key difference: IDEXX Laboratories, Inc. is far larger — about 3.6× Godaddy Inc's market cap. Which is the better fit depends on your goals.
| GDDY | IDXX | |
|---|---|---|
Market Cap | $12.09B | $43.94B |
Sector | Technology | Health |
52-Week High | $169.40 | $766.68 |
52-Week Low | $75.07 | $514.61 |
Enterprise Value | $14.67B | $44.84B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoDaddy (GDDY) trades at $91.10, showing modest daily gains. The stock presents a mixed picture: strong technical indicators signal a bullish trend, while fundamentals reveal robust profitability and consistent earnings beats. However, a high P/B ratio and ongoing securities litigation investigations introduce notable risks. The company continues to innovate, recently launching an AI-powered developer platform to expand its service ecosystem.
The outlook is cautiously optimistic. A significant analyst consensus price target of $123 suggests substantial upside potential, supported by strong cash flow and share buybacks. Primary risks include the high valuation on book value, legal overhang from shareholder investigations, and potential revenue growth deceleration. The stock's investment case hinges on execution of its AI initiatives and maintaining its margin profile.
IDXX stock trades at $540.68, down 4.15% in the last session, with technical indicators showing a bearish bias. Fundamentally, the company demonstrates strong profitability with a 24.63% net margin and consistent earnings beats in recent quarters. Revenue growth continues, reaching $4.3B in 2025. Analyst sentiment remains predominantly positive with a 59% buy rating, though technical signals conflict with this fundamental strength.
The outlook balances robust fundamentals against technical weakness. Investment opportunity lies in sustained high profitability and market leadership in veterinary diagnostics, but risks include elevated valuation multiples (P/E 40.99) and bearish technical momentum that may pressure the stock near-term despite positive analyst coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
